ANAB
ANAB
US0327241065
AnaptysBio, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 234.603.000 91.280.000
157.0%
Cost of Revenue -- --
--
Gross Profit -- --
--
7.701.000 25.128.000
69.4%
Operating Income 226.902.000 66.152.000
243.0%
Pretax Income 162.275.000 31.139.000
421.1%
Net Income Common Stockholders -13.232.000 -145.231.000
90.9%
-- --
--
-- --
--
ende